AI matches your study protocol against our donor database in seconds — not weeks. Fresh specimens from direct donor relationships, at a fraction of traditional CRO recruitment costs.
The biospecimen supply chain was designed for a world without AI. Research organizations pay a premium for inefficiency at every step.
Research coordinators spend weeks reviewing potential subjects against inclusion/exclusion criteria by hand.
IRB-approved consent forms still require in-person signatures at many institutions. Scheduling alone takes days.
Coordinators play phone tag with potential donors for weeks. Drop-off rates above 40% before the first draw.
The vast majority of traditional recruitment spend goes to coordination, not science. AI replaces the admin layer.
Four steps replace the entire CRO recruitment pipeline. Your team uploads criteria, our AI does the rest.
Each donor visit yields multiple specimen types — each matchable to different studies. One donor, many placements.
Every donor in our database is a living, searchable profile — not a frozen vial in a warehouse. Here's what a matched donor record looks like.
Every specimen ships with full documentation — Certificate of Analysis, chain of custody, and the complete de-identified donor profile.
Every specimen type we collect, with processing protocols and QC standards.
Structured tiers for every stage of research — from feasibility assessment to ongoing longitudinal access.
We're onboarding research partners now. Early access includes direct access to our specimen operations team and priority matching.
Accepting 5 new research accounts this quarter to ensure fulfillment quality.
We are not aggregating from existing biobanks or running trials. We build and maintain direct donor relationships, powered by AI operations.
Research data demands the highest standards of security and regulatory compliance. We built for this from day one.
Complete vendor documentation package — informed consent template, data security whitepaper, BAA summary, adverse event protocol, and specimen disposition policy.
Download IRB PackageThe team and the company behind Helio.
DTC growth strategist turned biotech operator. Previously led $100M+ in Meta ad spend for ecommerce brands. Now applying direct-to-consumer acquisition to the biospecimen supply chain.
Helio is a Philadelphia-based biospecimen marketplace. We own the donor relationship, partner with CLIA-certified labs for processing, and deliver matched specimens directly to research teams.
Our team will review your application and contact you within 24 hours to discuss your research needs and schedule a platform walkthrough.